| Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model KA Waugh, R Minter, J Baxter, C Chi, MD Galbraith, KD Tuttle, ... Nature genetics 55 (6), 1034-1047, 2023 | 30 | 2023 |
| Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition MD Galbraith, AL Rachubinski, KP Smith, P Araya, KA Waugh, ... Science Advances 9 (26), eadg6218, 2023 | 21 | 2023 |
| A toxicogenomic approach for the risk assessment of the food contaminant acetamide R Nault, B Bals, F Teymouri, MB Black, ME Andersen, PD McMullen, ... Toxicology and applied pharmacology 388, 114872, 2020 | 20 | 2020 |
| Proteasome inhibition sensitizes liposarcoma to MDM2 inhibition with Nutlin-3 by activating the ATF4/CHOP stress response pathway MP Ludwig, MD Galbraith, NP Eduthan, AA Hill, MR Clay, CM Tellez, ... Cancer Research 83 (15), 2543-2556, 2023 | 7 | 2023 |
| Interferon receptor gene dosage determines diverse hallmarks of Down syndrome KA Waugh, R Minter, J Baxter, C Chi, KD Tuttle, NP Eduthan, ... bioRxiv, 2022.02. 03.478982, 2022 | 5 | 2022 |
| Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome MG Donovan, NP Eduthan, KP Smith, EC Britton, HR Lyford, P Araya, ... Nature Communications 15 (1), 5473, 2024 | 4 | 2024 |
| JAK inhibition decreases the autoimmune burden in Down syndrome AL Rachubinski, E Wallace, E Gurnee, BA Enriquez-Estrada, KR Worek, ... medRxiv, 2024.06. 13.24308783, 2024 | 2 | 2024 |
| Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome MG Donovan, AL Rachubinski, KP Smith, P Araya, KA Waugh, ... Cell reports 43 (8), 2024 | 1 | 2024 |
| Integrated analysis of immunometabolic interactions in Down syndrome LA Gillenwater, MD Galbraith, AL Rachubinski, NP Eduthan, KD Sullivan, ... Science Advances 10 (50), eadq3073, 2024 | | 2024 |
| Heritable Variation in Lymphocyte-Related Traits and Risk of Down Syndrome Acute Lymphoblastic Leukemia: A Mendelian Randomization Study Y Li, MA Richard, L Kachuri, Y Yu, CJR Hsu, TC Rosser, EJ Leslie, ... Blood 142, 4198, 2023 | | 2023 |
| LIVER DYSFUNCTION IN DOWN SYNDROME L Dunn, K Kinning, N Eduthan, K Waugh, P Araya, K Schade, K Smith, ... HEPATOLOGY 78, S2114-S2115, 2023 | | 2023 |
| Clonal hematopoiesis in Down syndrome and its potential impact on hematopoietic lineages EJ Evans, N Paul-Eduthan, J Hu, D Gao, M Galbraith, J Espinosa, ... Cancer Research 83 (7_Supplement), 1510-1510, 2023 | | 2023 |
| Multi-Omics Assessment of Genetic Risk for Celiac Disease in Down Syndrome MG Stahl, JR Shaw, NP Eduthan, AL Rachubinski, KP Smith, BE Estrada, ... medRxiv, 2022.09. 27.22280436, 2022 | | 2022 |
| Development of New reporter systems for studying gamma butyrolactone mediated signaling in streptomyces NP Eduthan University of Minnesota, 2014 | | 2014 |
